Viridian Therapeutics (VRDN) Insider Trading & Ownership $19.23 +1.21 (+6.71%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$19.09 -0.14 (-0.73%) As of 08/22/2025 07:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Viridian Therapeutics (NASDAQ:VRDN) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage1.58%Number OfInsiders Buying(Last 12 Months)3Amount OfInsider Buying(Last 12 Months)$30.62MNumber OfInsiders Selling(Last 12 Months)0 Get VRDN Insider Trade Alerts Want to know when executives and insiders are buying or selling Viridian Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address VRDN Insider Buying and Selling by Quarter Viridian Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/27/2024Stephen F MahoneyCEOBuy21,400$23.33$499,262.00 9/27/2024Thomas W BeethamCOOBuy5,000$23.41$117,050.00 9/13/2024Fairmount Funds Management LlcDirectorBuy1,600,000$18.75$30,000,000.00 (Data available from 1/1/2013 forward) VRDN Insider Trading Activity - Frequently Asked Questions Who is on Viridian Therapeutics' Insider Roster? The list of insiders at Viridian Therapeutics includes Barrett Katz, Fairmount Funds Management Llc, Jonathan Violin, Lara Meisner, Scott Dunseth Myers, Stephen F Mahoney, and Thomas W Beetham. Learn more on insiders at VRDN. What percentage of Viridian Therapeutics stock is owned by insiders? 1.58% of Viridian Therapeutics stock is owned by insiders. Learn more on VRDN's insider holdings. Which Viridian Therapeutics insiders have been buying company stock? The following insiders have purchased VRDN shares in the last 24 months: Fairmount Funds Management Llc ($39,999,990.00), Stephen F Mahoney ($499,262.00), and Thomas W Beetham ($117,050.00). How much insider buying is happening at Viridian Therapeutics? Insiders have purchased a total of 2,102,590 VRDN shares in the last 24 months for a total of $40,616,302.00 bought. Viridian Therapeutics Key ExecutivesMr. Stephen F. Mahoney J.D. (Age 53)MBA, CEO, President & Director Dr. Eric N. Olson Ph.D.Co-Founder & Chairman of Scientific Advisory BoardDr. Michael R. Bristow M.D. (Age 79)Ph.D., Co-Founder & Member of the Scientific Advisory Board Dr. Marvin H. Caruthers Ph.D. (Age 84)Co-Founder & Scientific Advisory Board Member Mr. Vahe Bedian Ph.D.Co-Founder & Scientific AdvisorMr. Seth HarmonSenior VP of Finance and Accounting, Principal Financial & Accounting OfficerMr. Thomas W. Beetham J.D. (Age 54)MBA, Chief Operating Officer Ms. Jennifer Tousignant J.D.Chief Legal OfficerMr. John A. JordanVice President of Investor Relations & Corporate CommunicationsMr. Anthony Casciano (Age 47)Chief Commercial Officer More Insider Trading Tools from MarketBeat Related Companies RDNT Insider Trading OPCH Insider Trading SHC Insider Trading BTSG Insider Trading WGS Insider Trading SGRY Insider Trading PRVA Insider Trading VCYT Insider Trading ADUS Insider Trading LFST Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Buy, Sell, or Hold? Insiders Pile Into These 3 Healthcare StocksInsiders Trade Millions in NVIDIA-Linked Navitas, Hims, & Shift45 Stocks Insiders Are Selling That Analysts Say BuyStrategy Insiders Buy In While Analysts Predict Big UpsideThe Bottom Is in For These 3 Small-Cap Stocks Insiders Are Buying This page (NASDAQ:VRDN) was last updated on 8/24/2025 by MarketBeat.com Staff From Our PartnersNations are at war over what’s in this boxA resource known as Element 29 is quickly becoming one of the most sought-after materials on the planet. Goldm...Behind the Markets | SponsoredCould This Be the End of Retirement Worries?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTrump’s “new dollar” could shock Americans"I Made Millions in the Tech Boom. Here's Where I'd Put My Money Today" This man has called some of the big...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Viridian Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Viridian Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access